Arteris, INC Form 4 insider transactions

Arteris, Inc. President and CEO, K. Charles Janac, sold 40,000 shares of common stock for approximately $16.46 per share under a pre-arranged trading plan.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 438 shares of common stock to cover tax obligations from restricted stock unit release.

Arteris, Inc. President and CEO, Janac K Charles, reported sales of common stock totaling 3,304 shares in early December 2025, primarily for tax obligations and under a pre-arranged trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, reported the sale of 683 shares of common stock for tax obligations and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 814 shares of common stock in early December 2025, primarily to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised stock options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 plan.

Arteris, Inc. President and CEO, Janac K Charles, sold 50,000 shares of common stock for a weighted average price of $14.7366 per share under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported the sale of 50,000 shares of common stock at a weighted average price of $14.7366.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 32,775 shares of common stock for approximately $15.42 per share under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, K. Charles Janac, sold 50,000 shares of common stock for a weighted average price of $13.0742 per share under a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 50,000 shares of common stock for $13.0742 per share under a pre-arranged 10b5-1 trading plan.

Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., sold 6,421 shares of common stock for a weighted average price of $13.2073 per share under a Rule 10b5-1 trading plan.

Arteris, Inc. President and CEO, Janac K Charles, sold over 105,000 shares of common stock for approximately $1.4 million through a pre-arranged 10b5-1 trading plan.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 100,000 shares of common stock for a weighted average price of $13.1045 per share.

Arteris Director Antonio J. Viana sold 11,841 shares of common stock at $14 per share on October 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold a total of 7,627 shares of common stock in early October 2025, primarily to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Chief Operating Officer Laurent R. Moll sold 42,516 shares of common stock in early October 2025, primarily under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, K. Charles Janac, reported sales of common stock totaling 18,968 shares in early October 2025, primarily for tax obligations and under a pre-arranged trading plan.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 3,887 shares of common stock on October 2, 2025, at $10.9208 per share to cover tax liabilities from restricted stock unit releases.

Arteris, Inc. Director Joachim Kunkel acquired 1,496 shares of common stock as fully vested restricted stock in lieu of cash retainer fees.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold 5,000 shares of common stock for over $10 per share after exercising options.

Arteris VP and General Counsel Paul Alpern exercised options and subsequently sold an equal number of common shares under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s VP and CFO, Nicholas B. Hawkins, sold 3,660 shares of common stock for a weighted average price of $8.6903, executed under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold a total of 2,702 shares of common stock in early September 2025 under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 12,978 shares of common stock in early September 2025 under a pre-arranged 10b5-1 trading plan.

Arteris President and CEO, K. Charles Janac, sold 2,057 shares of common stock for approximately $8.73 per share under a pre-arranged trading plan.

Arteris Inc. Director Wayne C. Cantwell transferred 228,198 shares of common stock to The Cantwell Living Trust.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 42,692 shares of common stock on September 2, 2025, to cover tax liabilities from restricted stock unit releases.

Arteris, Inc. President and CEO, Janac K Charles, sold 1,246 shares of common stock to cover tax liabilities related to restricted stock unit release.